Kweli P. Thompson, MD, MPH

He pursues broad impact to peoples’ lives by delivering innovative technologies and is committed to solutions that treat more diverse populations.

As Executive Vice President and President of the Neuroscience Portfolio at Medtronic, the global leader in medical technology, Dr. Thompson oversees five unique Operating Units — Cranial & Spinal Technologies, Ear, Nose and Throat, Neuromodulation, Neurovascular, and Pelvic Health – which generate more than $8B in annual revenue and employ approximately 15,000 employees worldwide. He is a member of the company’s executive committee.

Previously, he served as Senior Vice President and Operating Unit President for Cardiac Rhythm Management; Vice President and General Manager of Defibrillation Solutions business; led Cardiac Resynchronization Therapies business; served as Vice President of Clinical Affairs for the Cardiac and Vascular Group; Vice President of global marketing for the Endovascular Innovations business; and Vice President of global clinical research for the Cardiovascular business, which included his leadership in an unprecedented collaboration with the United States Food and Drug Administration, other stent manufacturers, pharmaceutical companies and the Harvard Clinical Research Institute to design a comprehensive international clinical study.

A strong believer in servant leadership and helping others achieve their goals and objectives, Thompson has served on the board of The Blake School (Minneapolis) and he currently serves on the board of the worldrenowned Guthrie Theater. He is also a published author on the topic of cardiac stents and training procedures. Thompson holds a Bachelor of Arts from Harvard College, a Master’s in Public Health from the Harvard School of Public Health, a Master’s in Business Administration from the Harvard Business School, and a Doctor of Medicine from the Harvard Medical School.